Lime Chemicals Ltd (507759)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Lime Chemicals' revenue was ₹6.2 Cr (+236.7% year on year, +173.2% on the previous quarter), and net profit ₹0.2 Cr (+548.7% year on year); the operating margin was 2.9%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹6.2 | +236.7% | +173.2% |
| Operating profit | ₹0.2 | from loss | from loss |
| Net profit | ₹0.2 | +548.7% | +548.7% |
| EPS (₹) | 0.31 | +520.0% | +520.0% |
| Operating margin | 2.9% | — | — |
📢 Recent Corporate Announcements
Lime Chemicals Ltd has approved its unaudited standalone financial results for the quarter ended June 30, 2026, at its board meeting held on August 14, 2026. Statutory auditors R. A. Kuvadia & Co issued a limited review report with an unmodified opinion. The auditor highlighted an 'Other Matter' note regarding outstanding payments due to an MSME entity. Specific quarterly revenue and net profit figures were omitted from the filing extract.
- Board approved unaudited standalone financial results for the quarter ended June 30, 2026 on August 14, 2026
- Statutory auditor R. A. Kuvadia & Co issued an unmodified review report under Regulation 33
- Auditor drew attention to Note No. 3 regarding payments due to an MSME
- Board meeting commenced at 3:30 p.m. and concluded at 4:15 p.m.
Lime Chemicals Limited has approved its unaudited standalone financial results for the quarter ended June 30, 2026. The statutory auditor, R. A. Kuvadia & Co., issued an unmodified review report for the quarter. In their emphasis of matter, the auditors highlighted Note No 3 regarding overdue payments due to a Micro, Small, and Medium Enterprise (MSME). The detailed financial statements and P&L figures were not attached in the provided filing extract.
- Board approved unaudited standalone financial results for the quarter ended June 30, 2026
- Statutory auditor issued an unmodified limited review report with no audit qualifications
- Auditor drew attention to Note No 3 regarding pending payments due to an MSME
- Board meeting commenced at 3:30 p.m. and concluded at 4:15 p.m. on August 14, 2026
Lime Chemicals Ltd has received a formal order from the Regional Director, Western Region-II, approving the relocation of its registered office. The office will move from Navi Mumbai (ROC Mumbai-II jurisdiction) to Vile Parle West, Mumbai (ROC Mumbai-I jurisdiction). This administrative change follows a special resolution passed by shareholders on April 21, 2026. The company has explicitly stated that this move will have no impact on its financial or operational performance.
- Order dated August 7, 2026, received from the Regional Director, Ministry of Corporate Affairs
- Registered office shifting from Navi Mumbai (400614) to Vile Parle West, Mumbai (400056)
- Change in jurisdiction from ROC Mumbai-II to ROC Mumbai-I within Maharashtra
- Special Resolution for the move was previously passed by members on April 21, 2026
Lime Chemicals Ltd has announced a leadership transition with the resignation of Chairman Avinash Jhaveri effective August 04, 2026. The board has appointed Mr. Samir Kumar Das, an insolvency professional with over 30 years of BFSI experience (including SBI and ICICI Bank), as the new Chairman. Additionally, Ms. Rakhi Jayantilal Upadhay joins as an Independent Director with 25 years of experience in financial due diligence. This change occurs as the company manages a small revenue base of Rs 7 Cr and a high debt-to-equity ratio of 2.67.
- Mr. Avinash Jhaveri resigned as Chairman and Independent Director effective August 04, 2026.
- New Chairman Mr. Samir Kumar Das brings 30+ years of leadership experience in BFSI and stressed asset resolution.
- Ms. Rakhi Upadhay appointed as Independent Director with 25+ years of experience in financial consulting.
- The company currently operates with a high debt of Rs 5 Cr against a small net worth of Rs 2 Cr.
- Audit and Risk Management committees have been reconstituted following these appointments.
Lime Chemicals has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company is a micro-cap entity with a market capitalization of just ₹9 Cr and TTM revenue of ₹7.12 Cr. Recent performance has been weak, with a net loss of ₹0.17 Cr in FY26 and a negative ROCE of -2.0%. Investors will be looking for signs of recovery from the -6.6% operating margins reported on a TTM basis.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
- Company reported a TTM revenue of ₹7.12 Cr against a market cap of ₹9 Cr
- Debt-to-Equity ratio remains high at 2.67 with total debt of ₹5 Cr
- Promoter holding has remained stagnant at 29.27% as of June 2026
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
